Pnc Financial Services Group, Inc. Avidity Biosciences, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 452 shares of RNA stock, worth $13,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
452
Previous 411
9.98%
Holding current value
$13,939
Previous $18,000
27.78%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RNA
# of Institutions
257Shares Held
100MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$341 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$291 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$266 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$245 Million3.76% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.5MShares$231 Million3.18% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.61B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...